PAG
GILD icon

Poinciana Advisors Group’s Gilead Sciences GILD Stock Holding History

Poinciana Advisors Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$404K Hold
3,196
– – 0.3% 58
2026
Q1 		$445K Hold
3,196
– – 0.35% 45
2025
Q4 		$392K Sell
3,196
-11
-0.3% -$1.34K 0.31% 56
2025
Q3 		$356K Buy
3,207
+1
+0% +$114 0.3% 60
2025
Q2 		$355K Buy
3,206
+10
+0.3% +$1.06K 0.32% 57
2025
Q1 		$358K Sell
3,196
-16
-0.5% -$1.65K 0.37% 44
2024
Q4 		$297K Buy
+3,212
New +$289K 0.3% 56

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Poinciana Advisors Group's GILD Position: Q2 2026 in Review

Poinciana Advisors Group held its Gilead Sciences (GILD) position steady in Q2 2026 at 3,196 shares worth $404K. The position accounts for 0.3% of the portfolio, ranked #58.

Poinciana Advisors Group first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $445K in Q1 2026. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Poinciana Advisors Group held 3,196 shares of Gilead Sciences worth $404K as of Q2 2026.
  • Poinciana Advisors Group left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.3% of Poinciana Advisors Group's portfolio in Q2 2026, its #58 holding.
  • Poinciana Advisors Group first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Poinciana Advisors Group's Gilead Sciences position peaked at $445K in Q1 2026.
  • 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Poinciana Advisors Group's 13F filing for Q2 2026, filed 28 Jul 2026.